Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia
Clinical trial NCT06056570 · COMPLETED
Trial details
- NCT number
- NCT06056570
- Sponsor
- Urica Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2024-06-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.